Type | Standard / Implementation Specification | Standards Process Maturity | Implementation Maturity | Adoption Level | Federally required | Cost | Test Tool Availability |
---|---|---|---|---|---|---|---|
Standard
|
Final
|
Production
|
![]() |
Yes
|
Free
|
N/A
|
|
Standard
|
Final
|
Production
|
![]() |
Yes
|
Free
|
N/A
|
|
Standard
|
Final
|
Production
|
![]() |
No
|
Free
|
N/A
|
|
Standard
|
Final
|
Production
|
![]() |
No
|
$
|
No
|
|
Standard
|
Final
|
Production
|
Feedback Requested |
No
|
Free
|
N/A
|
Limitations, Dependencies, and Preconditions for Consideration | Applicable Value Set(s) and Starter Set(s) |
---|---|
General considerations:
For Immunization Information System (IIS) consideration:
|
Comment
Submitted by Albert Taylor
on 2017-12-11
added value of RxNorm
Given the uptake of CVX/MVX standards, what would the added value of RxNorm be in representing vaccines over CVX/MVX along?
Submitted by rmcclure on 2017-10-04
Agree with the code system…
Agree with the code system and value set identified. The VSAC direct url for this value set is https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1010.6/expansion.
I would like to also have the ISA include RxNorm as an additional code system to describe vaccines. That value set is Vaccine Clinical Drug 2.16.840.1.113762.1.4.1010.8 https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1010.8/expansion